HUTCHMED Cost Of Revenue vs Capex To Revenue Analysis

HCM Stock

USD 14.20 0.88 6.61%

HUTCHMED DRC financial indicator trend analysis is much more than just examining HUTCHMED DRC latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether HUTCHMED DRC is a good investment. Please check the relationship between HUTCHMED DRC Cost Of Revenue and its Capex To Revenue accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in HUTCHMED DRC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

To learn how to invest in HUTCHMED Stock, please use our How to Invest in HUTCHMED DRC guide.

Cost Of Revenue vs Capex To Revenue

Cost Of Revenue vs Capex To Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of HUTCHMED DRC Cost Of Revenue account and Capex To Revenue. At this time, the significance of the direction appears to have very week relationship.

The correlation between HUTCHMED DRC's Cost Of Revenue and Capex To Revenue is 0.2. Overlapping area represents the amount of variation of Cost Of Revenue that can explain the historical movement of Capex To Revenue in the same time period over historical financial statements of HUTCHMED DRC, assuming nothing else is changed. The correlation between historical values of HUTCHMED DRC's Cost Of Revenue and Capex To Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cost Of Revenue of HUTCHMED DRC are associated (or correlated) with its Capex To Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capex To Revenue has no effect on the direction of Cost Of Revenue i.e., HUTCHMED DRC's Cost Of Revenue and Capex To Revenue go up and down completely randomly.

Correlation Coefficient

0.2

Relationship Direction	Positive
Relationship Strength	Very Weak

View All Relationships

Cost Of Revenue

Cost of Revenue is found on HUTCHMED DRC income statement and represents the costs associated with goods and services HUTCHMED DRC provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Capex To Revenue

The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.

Most indicators from HUTCHMED DRC's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into HUTCHMED DRC current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in HUTCHMED DRC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

To learn how to invest in HUTCHMED Stock, please use our How to Invest in HUTCHMED DRC guide.At this time, HUTCHMED DRC's Discontinued Operations is very stable compared to the past year. As of the 18th of January 2025, Sales General And Administrative To Revenue is likely to grow to 0.21, while Tax Provision is likely to drop about 4.5 M.

	2022	2023	2024	2025 (projected)
Interest Expense	652K	759K	872.9K	879.4K
Depreciation And Amortization	8.7M	8.2M	9.4M	4.9M

Interest Expense Depreciation And Amortization

HUTCHMED DRC fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Common Stock Shares Outstanding	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock Total Equity	Short Term Investments	Common Stock
Total Assets		0.63	0.93	0.95	0.98	0.92	0.6	-0.85	-0.91	0.6	0.96	0.6	0.42	1.0	-0.28	0.86	-0.08	0.99	0.93	0.94	1.0	0.3	-0.41	0.64	0.98	0.88
Short Long Term Debt Total	0.63		0.58	0.7	0.52	0.69	0.13	-0.2	-0.51	0.15	0.5	0.35	-0.3	0.61	-0.75	0.58	-0.35	0.59	0.78	0.64	0.62	0.68	-0.32	0.21	0.64	0.42
Other Current Liab	0.93	0.58		0.98	0.87	0.95	0.42	-0.8	-0.93	0.6	0.91	0.46	0.33	0.93	-0.38	0.92	-0.11	0.95	0.95	0.92	0.94	0.27	-0.29	0.48	0.92	0.82
Total Current Liabilities	0.95	0.7	0.98		0.88	0.98	0.43	-0.76	-0.94	0.57	0.91	0.46	0.25	0.94	-0.45	0.94	-0.17	0.97	0.99	0.95	0.96	0.36	-0.3	0.49	0.93	0.82
Total Stockholder Equity	0.98	0.52	0.87	0.88		0.83	0.67	-0.88	-0.86	0.6	0.95	0.64	0.54	0.98	-0.15	0.78	-0.03	0.96	0.85	0.89	0.98	0.24	-0.45	0.69	0.96	0.88
Property Plant And Equipment Net	0.92	0.69	0.95	0.98	0.83		0.42	-0.73	-0.92	0.51	0.89	0.38	0.18	0.91	-0.5	0.96	-0.09	0.94	0.98	0.95	0.93	0.3	-0.17	0.44	0.9	0.78
Current Deferred Revenue	0.6	0.13	0.42	0.43	0.67	0.42		-0.75	-0.46	0.27	0.7	0.32	0.74	0.63	0.18	0.36	0.2	0.56	0.39	0.39	0.61	-0.03	-0.24	0.42	0.57	0.54
Net Debt	-0.85	-0.2	-0.8	-0.76	-0.88	-0.73	-0.75		0.87	-0.75	-0.94	-0.57	-0.76	-0.85	-0.16	-0.74	-0.15	-0.87	-0.69	-0.72	-0.85	0.04	0.29	-0.63	-0.77	-0.85
Retained Earnings	-0.91	-0.51	-0.93	-0.94	-0.86	-0.92	-0.46	0.87		-0.75	-0.93	-0.58	-0.41	-0.89	0.2	-0.91	0.0	-0.96	-0.9	-0.9	-0.91	-0.13	0.31	-0.58	-0.84	-0.88
Accounts Payable	0.6	0.15	0.6	0.57	0.6	0.51	0.27	-0.75	-0.75		0.69	0.73	0.53	0.56	0.31	0.61	-0.02	0.65	0.51	0.51	0.57	-0.15	-0.31	0.65	0.46	0.75
Cash	0.96	0.5	0.91	0.91	0.95	0.89	0.7	-0.94	-0.93	0.69		0.59	0.56	0.96	-0.11	0.86	0.03	0.97	0.88	0.86	0.96	0.18	-0.35	0.61	0.9	0.88
Non Current Assets Total	0.6	0.35	0.46	0.46	0.64	0.38	0.32	-0.57	-0.58	0.73	0.59		0.34	0.56	0.15	0.34	0.04	0.59	0.46	0.47	0.55	0.02	-0.72	0.88	0.5	0.77
Non Currrent Assets Other	0.42	-0.3	0.33	0.25	0.54	0.18	0.74	-0.76	-0.41	0.53	0.56	0.34		0.44	0.63	0.23	0.28	0.43	0.14	0.22	0.43	-0.31	-0.21	0.41	0.36	0.49
Cash And Short Term Investments	1.0	0.61	0.93	0.94	0.98	0.91	0.63	-0.85	-0.89	0.56	0.96	0.56	0.44		-0.3	0.85	-0.08	0.98	0.92	0.94	1.0	0.31	-0.39	0.61	0.99	0.87
Common Stock Shares Outstanding	-0.28	-0.75	-0.38	-0.45	-0.15	-0.5	0.18	-0.16	0.2	0.31	-0.11	0.15	0.63	-0.3		-0.36	0.36	-0.26	-0.54	-0.43	-0.3	-0.57	0.0	0.13	-0.4	-0.09
Inventory	0.86	0.58	0.92	0.94	0.78	0.96	0.36	-0.74	-0.91	0.61	0.86	0.34	0.23	0.85	-0.36		-0.07	0.9	0.93	0.91	0.88	0.22	0.0	0.42	0.82	0.75
Other Current Assets	-0.08	-0.35	-0.11	-0.17	-0.03	-0.09	0.2	-0.15	0.0	-0.02	0.03	0.04	0.28	-0.08	0.36	-0.07		-0.04	-0.18	-0.1	-0.09	-0.48	0.21	0.13	-0.14	0.01
Other Stockholder Equity	0.99	0.59	0.95	0.97	0.96	0.94	0.56	-0.87	-0.96	0.65	0.97	0.59	0.43	0.98	-0.26	0.9	-0.04		0.94	0.95	0.99	0.24	-0.38	0.62	0.95	0.89
Total Liab	0.93	0.78	0.95	0.99	0.85	0.98	0.39	-0.69	-0.9	0.51	0.88	0.46	0.14	0.92	-0.54	0.93	-0.18	0.94		0.95	0.93	0.38	-0.29	0.47	0.92	0.78
Property Plant And Equipment Gross	0.94	0.64	0.92	0.95	0.89	0.95	0.39	-0.72	-0.9	0.51	0.86	0.47	0.22	0.94	-0.43	0.91	-0.1	0.95	0.95		0.95	0.27	-0.28	0.56	0.94	0.82
Total Current Assets	1.0	0.62	0.94	0.96	0.98	0.93	0.61	-0.85	-0.91	0.57	0.96	0.55	0.43	1.0	-0.3	0.88	-0.09	0.99	0.93	0.95		0.3	-0.36	0.6	0.98	0.87
Short Term Debt	0.3	0.68	0.27	0.36	0.24	0.3	-0.03	0.04	-0.13	-0.15	0.18	0.02	-0.31	0.31	-0.57	0.22	-0.48	0.24	0.38	0.27	0.3		-0.09	-0.15	0.36	0.08
Intangible Assets	-0.41	-0.32	-0.29	-0.3	-0.45	-0.17	-0.24	0.29	0.31	-0.31	-0.35	-0.72	-0.21	-0.39	0.0	0.0	0.21	-0.38	-0.29	-0.28	-0.36	-0.09		-0.54	-0.38	-0.44
Common Stock Total Equity	0.64	0.21	0.48	0.49	0.69	0.44	0.42	-0.63	-0.58	0.65	0.61	0.88	0.41	0.61	0.13	0.42	0.13	0.62	0.47	0.56	0.6	-0.15	-0.54		0.57	0.84
Short Term Investments	0.98	0.64	0.92	0.93	0.96	0.9	0.57	-0.77	-0.84	0.46	0.9	0.5	0.36	0.99	-0.4	0.82	-0.14	0.95	0.92	0.94	0.98	0.36	-0.38	0.57		0.83
Common Stock	0.88	0.42	0.82	0.82	0.88	0.78	0.54	-0.85	-0.88	0.75	0.88	0.77	0.49	0.87	-0.09	0.75	0.01	0.89	0.78	0.82	0.87	0.08	-0.44	0.84	0.83

Click cells to compare fundamentals

HUTCHMED DRC Account Relationship Matchups

HUTCHMED DRC fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	724.1M	1.4B	1.0B	1.3B	1.5B	1.5B
Short Long Term Debt Total	35.7M	34.1M	23.3M	86.1M	99.1M	104.0M
Other Current Liab	122.9M	228.0M	278.0M	271.4M	312.1M	327.7M
Total Current Liabilities	158.4M	311.7M	353.9M	403.0M	463.5M	486.7M
Total Stockholder Equity	484.1M	986.9M	610.4M	730.5M	840.1M	882.1M
Property Plant And Equipment Net	45.3M	66.3M	84.7M	104.4M	120.1M	126.1M
Current Deferred Revenue	123.6M	226.4M	13.3M	57.6M	66.3M	69.6M
Net Debt	(199.9M)	(343.5M)	(290.0M)	(197.5M)	(177.7M)	(168.8M)
Retained Earnings	(415.6M)	(610.3M)	(971.5M)	(870.9M)	(783.8M)	(744.6M)
Accounts Payable	31.6M	41.2M	71.1M	36.3M	41.8M	24.7M
Cash	235.6M	377.5M	313.3M	283.6M	326.1M	342.4M
Non Current Assets Total	193.4M	160.6M	189.6M	182.9M	210.4M	122.5M
Non Currrent Assets Other	203.1M	639.0M	327.1M	11.6M	13.3M	12.7M
Cash And Short Term Investments	435.2M	1.0B	631.0M	886.3M	1.0B	1.1B
Common Stock Shares Outstanding	697.9M	792.7M	847.1M	173.8M	199.9M	189.9M
Liabilities And Stockholders Equity	724.1M	1.4B	1.0B	1.3B	1.5B	1.5B
Inventory	19.8M	35.8M	56.7M	50.3M	57.8M	60.7M
Other Current Assets	75.8M	16.9M	25.5M	9.8M	11.3M	10.7M
Other Stockholder Equity	822.5M	1.5B	1.5B	1.5B	1.7B	1.8B
Total Liab	205.2M	333.1M	392.6M	536.4M	616.8M	647.7M
Property Plant And Equipment Gross	45.3M	99.2M	121.5M	151.0M	173.6M	182.3M
Total Current Assets	530.7M	1.2B	839.9M	1.1B	1.3B	1.3B
Accumulated Other Comprehensive Income	4.5M	5.6M	(1.9M)	(8.2M)	(9.4M)	(9.9M)
Short Term Debt	2.8M	26.9M	3.7M	35.1M	40.3M	42.4M
Intangible Assets	227K	163K	3.2M	21K	18.9K	18.0K
Short Term Investments	199.5M	634.2M	317.7M	602.7M	693.2M	727.8M
Common Stock	72.8M	86.5M	86.5M	87.1M	100.2M	68.2M
Net Receivables	47.9M	147.7M	126.7M	150.5M	173.0M	181.7M
Non Current Liabilities Total	46.8M	21.5M	38.7M	133.4M	153.4M	161.0M
Good Will	3.1M	3.3M	3.4M	3.1M	2.8M	2.6M
Other Liab	8.7M	13.3M	14.3M	15.4M	17.7M	10.1M
Net Tangible Assets	284.6M	480.6M	983.4M	610.4M	701.9M	394.5M
Other Assets	18.2M	27.4M	31.1M	1.0	1.15	1.09
Property Plant Equipment	26.4M	32.2M	53.2M	84.7M	97.4M	102.2M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether HUTCHMED DRC is a strong investment it is important to analyze HUTCHMED DRC's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact HUTCHMED DRC's future performance. For an informed investment choice regarding HUTCHMED Stock, refer to the following important reports:

How To Invest In HUTCHMED

Details

Is HUTCHMED Stock a good investment?

Details

What is HUTCHMED DRC's Net Worth?

Details

Largest Pharmaceuticals Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in HUTCHMED DRC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

To learn how to invest in HUTCHMED Stock, please use our How to Invest in HUTCHMED DRC guide.

You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of HUTCHMED DRC. If investors know HUTCHMED will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about HUTCHMED DRC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.84)

Earnings Share

(0.25)

Revenue Per Share

3.575

Quarterly Revenue Growth

(0.43)

Return On Assets

(0.06)

The market value of HUTCHMED DRC is measured differently than its book value, which is the value of HUTCHMED that is recorded on the company's balance sheet. Investors also form their own opinion of HUTCHMED DRC's value that differs from its market value or its book value, called intrinsic value, which is HUTCHMED DRC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because HUTCHMED DRC's market value can be influenced by many factors that don't directly affect HUTCHMED DRC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between HUTCHMED DRC's value and its price as these two are different measures arrived at by different means. Investors typically determine if HUTCHMED DRC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, HUTCHMED DRC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

HUTCHMED Cost Of Revenue vs Capex To Revenue Analysis

Cost Of Revenue vs Capex To Revenue

Cost Of Revenue vs Capex To Revenue Correlation Analysis

Correlation Coefficient

Cost Of Revenue

Capex To Revenue

HUTCHMED DRC fundamental ratios Correlations

HUTCHMED DRC Account Relationship Matchups

High Positive Relationship

High Negative Relationship

HUTCHMED DRC fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Cash And Short Term Investments
Other Stockholder Equity	+ 0.99	Total Assets
Total Liab	+ 0.99	Total Current Liabilities
Short Term Investments	+ 0.99	Cash And Short Term Investments

Other Stockholder Equity	- 0.96	Retained Earnings
Cash	- 0.94	Net Debt
Retained Earnings	- 0.94	Total Current Liabilities
Cash	- 0.93	Retained Earnings
Retained Earnings	- 0.93	Other Current Liab
Retained Earnings	- 0.92	Property Plant And Equipment Net